OUTBRAIN INC (OB) Fundamental Analysis & Valuation

NASDAQ:OBUS69002R1032

Current stock price

2.74 USD
-0.07 (-2.49%)
At close:
2.8 USD
+0.06 (+2.19%)
After Hours:

This OB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. OB Profitability Analysis

1.1 Basic Checks

  • OB had negative earnings in the past year.
  • In the past year OB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: OB reported negative net income in multiple years.
  • OB had a positive operating cash flow in each of the past 5 years.
OB Yearly Net Income VS EBIT VS OCF VS FCFOB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

  • OB's Return On Assets of -2.99% is in line compared to the rest of the industry. OB outperforms 49.30% of its industry peers.
  • OB has a Return On Equity (-10.64%) which is in line with its industry peers.
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROIC N/A
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
OB Yearly ROA, ROE, ROICOB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • With a Gross Margin value of 24.31%, OB is not doing good in the industry: 84.51% of the companies in the same industry are doing better.
  • OB's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for OB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
OB Yearly Profit, Operating, Gross MarginsOB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. OB Health Analysis

2.1 Basic Checks

  • OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OB has been increased compared to 1 year ago.
  • Compared to 5 years ago, OB has less shares outstanding
  • There is no outstanding debt for OB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OB Yearly Shares OutstandingOB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OB Yearly Total Debt VS Total AssetsOB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • OB has an Altman-Z score of 0.50. This is a bad value and indicates that OB is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.50, OB perfoms like the industry average, outperforming 42.25% of the companies in the same industry.
  • The Debt to FCF ratio of OB is 15.66, which is on the high side as it means it would take OB, 15.66 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 15.66, OB is in line with its industry, outperforming 52.11% of the companies in the same industry.
  • A Debt/Equity ratio of 1.32 is on the high side and indicates that OB has dependencies on debt financing.
  • OB has a worse Debt to Equity ratio (1.32) than 80.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Altman-Z 0.5
ROIC/WACCN/A
WACC8.68%
OB Yearly LT Debt VS Equity VS FCFOB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • OB has a Current Ratio of 1.13. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.13, OB is not doing good in the industry: 76.06% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.13 indicates that OB should not have too much problems paying its short term obligations.
  • OB's Quick ratio of 1.13 is on the low side compared to the rest of the industry. OB is outperformed by 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
OB Yearly Current Assets VS Current LiabilitesOB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. OB Growth Analysis

3.1 Past

  • OB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
  • Looking at the last year, OB shows a small growth in Revenue. The Revenue has grown by 4.16% in the last year.
  • The Revenue has been growing slightly by 5.30% on average over the past years.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%

3.2 Future

  • OB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 101.45% yearly.
  • Based on estimates for the next years, OB will show a small growth in Revenue. The Revenue will grow by 7.84% on average per year.
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OB Yearly Revenue VS EstimatesOB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
OB Yearly EPS VS EstimatesOB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

6

4. OB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OB. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 3.30 indicates a rather cheap valuation of OB.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of OB indicates a rather cheap valuation: OB is cheaper than 100.00% of the companies listed in the same industry.
  • OB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.29.
Industry RankSector Rank
PE N/A
Fwd PE 3.3
OB Price Earnings VS Forward Price EarningsOB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of OB indicates a rather cheap valuation: OB is cheaper than 94.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.45
EV/EBITDA N/A
OB Per share dataOB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • OB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as OB's earnings are expected to grow with 101.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y355.64%
EPS Next 3Y101.45%

0

5. OB Dividend Analysis

5.1 Amount

  • No dividends for OB!.
Industry RankSector Rank
Dividend Yield N/A

OB Fundamentals: All Metrics, Ratios and Statistics

OUTBRAIN INC

NASDAQ:OB (6/9/2025, 8:00:02 PM)

After market: 2.8 +0.06 (+2.19%)

2.74

-0.07 (-2.49%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-09
Earnings (Next)08-06
Inst OwnersN/A
Inst Owner Change-14.63%
Ins OwnersN/A
Ins Owner Change0%
Market Cap258.38M
Revenue(TTM)959.27M
Net Income(TTM)-50.51M
Analysts78.46
Price Target5.44 (98.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.21%
Min EPS beat(2)-102.79%
Max EPS beat(2)-17.62%
EPS beat(4)2
Avg EPS beat(4)50.06%
Min EPS beat(4)-102.79%
Max EPS beat(4)284.85%
EPS beat(8)5
Avg EPS beat(8)515.51%
EPS beat(12)7
Avg EPS beat(12)306.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.58%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-0.62%
Revenue beat(4)0
Avg Revenue beat(4)-5.74%
Min Revenue beat(4)-9.09%
Max Revenue beat(4)-0.62%
Revenue beat(8)0
Avg Revenue beat(8)-5.76%
Revenue beat(12)2
Avg Revenue beat(12)-3.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.42%
PT rev (3m)-35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-180.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)28.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.3
P/S 0.27
P/FCF 6.45
P/OCF 4.38
P/B 0.54
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.83
Fwd EY30.31%
FCF(TTM)0.42
FCFY15.5%
OCF(TTM)0.63
OCFY22.83%
SpS10.17
BVpS5.03
TBVpS-5.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.31%
FCFM 4.17%
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Debt/EBITDA N/A
Cap/Depr 69.03%
Cap/Sales 1.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 0.5
F-Score4
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)94.29%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A
EBIT growth 1Y-360.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3702.14%
EBIT Next 3Y261.82%
EBIT Next 5YN/A
FCF growth 1Y199.3%
FCF growth 3Y11.78%
FCF growth 5Y51.85%
OCF growth 1Y520.46%
OCF growth 3Y6.5%
OCF growth 5Y32.58%

OUTBRAIN INC / OB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OUTBRAIN INC?

ChartMill assigns a fundamental rating of 3 / 10 to OB.


What is the valuation status for OB stock?

ChartMill assigns a valuation rating of 6 / 10 to OUTBRAIN INC (OB). This can be considered as Fairly Valued.


Can you provide the profitability details for OUTBRAIN INC?

OUTBRAIN INC (OB) has a profitability rating of 2 / 10.


How financially healthy is OUTBRAIN INC?

The financial health rating of OUTBRAIN INC (OB) is 3 / 10.